Microbiome and Association With Implant Infections

PHASE2RecruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

September 28, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Breast CancerBreast Cancer FemaleGenetic Predisposition to Disease

Interventions

DRUG

Cephalexin

Given orally (PO)

Trial Locations (1)

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors

collaborator

The Plastic Surgery Foundation

OTHER

lead

University of California, San Francisco

OTHER